Gender Bias in Diagnosis, Prevention, and Treatment of Cardiovascular Diseases: A Systematic Review.

cardiovascular disease prevention cardiovascular diseases (cvd) diagnosis and treatment gender bias women’s health

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Feb 2024
Historique:
accepted: 14 02 2024
medline: 19 3 2024
pubmed: 19 3 2024
entrez: 19 3 2024
Statut: epublish

Résumé

Cardiovascular disease (CVDs) has been perceived as a 'man's disease', and this impacted women's referral to CVD diagnosis and treatment. This study systematically reviewed the evidence regarding gender bias in the diagnosis, prevention, and treatment of CVDs. Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed. We searched CINAHL, PubMed, Medline, Web of Science, British Nursing Index, Scopus, and Google Scholar. The included studies were assessed for quality using risk bias tools. Data extracted from the included studies were exported into Statistical Product and Service Solutions (SPSS, v26; IBM SPSS Statistics for Windows, Armonk, NY), where descriptive statistics were applied. A total of 19 studies were analysed. CVDs were less reported among women who either showed milder symptoms than men or had their symptoms misdiagnosed as gastrointestinal or anxiety-related symptoms. Hence, women had their risk factors under-considered by physicians (especially by male physicians). Subsequently, women were offered fewer diagnostic tests, such as coronary angiography, ergometry, electrocardiogram (ECG), and cardiac enzymes, and were referred to less to cardiologists and/or hospitalisation. Furthermore, if hospitalised, women were less likely to receive a coronary intervention. Similarly, women were prescribed cardiovascular medicines than men, with the exception of antihypertensive and anti-anginal medicines. When it comes to the perception of CVD, women considered themselves at lower risk of CVDs than men. This systematic review showed that women were offered fewer diagnostic tests for CVDs and medicines than men and that in turn influenced their disease outcomes. This could be attributed to the inadequate knowledge regarding the differences in manifestations among both genders.

Identifiants

pubmed: 38500942
doi: 10.7759/cureus.54264
pmc: PMC10945154
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e54264

Informations de copyright

Copyright © 2024, Al Hamid et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Abdullah Al Hamid (A)

Pharmacy Practice, King Faisal University, Al Ahsa, SAU.

Rachel Beckett (R)

Forensic Science, Liverpool John Moores University, Liverpool, GBR.

Megan Wilson (M)

Forensic Science, Liverpool John Moores University, Liverpool, GBR.

Zahra Jalal (Z)

Pharmacology and Therapeutics, Birmingham University, Birmingham, GBR.

Ejaz Cheema (E)

Pharmacy, University of Management and Technology, Lahore, PAK.

Dhiya Al-Jumeily Obe (D)

Computer Science and Mathematics, Liverpool John Moores University, Liverpool, GBR.

Thomas Coombs (T)

Toxicology, British American Tobacco, Southampton, GBR.

Komang Ralebitso-Senior (K)

Forensic Science, Liverpool John Moores University, Liverpool, GBR.

Sulaf Assi (S)

Pharmacy, Liverpool John Moores University, Liverpool, GBR.

Classifications MeSH